Directory Antineoplastic funds Antineoplastic hormonal and hormone antagonists Omnadren 250
This page is translated automatically with a help of Google Translate

Omnadren 250

See also Testosterone

Roman name

Omnadren 250

Pharmacokinetics

The farmakokinetike drug Omnadren 250 is not provided.

Farmakodinamika

It stimulates the synthesis of protein, delaying needed for the ion potassium, sulphur, phosphorus, a record increase of calcium in the bones, increases muscle weight. Affects development and the external genital organs, prostate, seed bubbles secondary sexual characteristics (voice, the hair cover). Identifies constitution body and the sexual behavior, activates and sexual potency, stimulates spermatogenez. Is antagonist female sexual hormones-estrogen. Ters negative manifestations of menopause.

Clinical pharmacology

Members of the drug testosterone esters have different speeds and suction out, which allows for rapid and long-term (up to four weeks) effect after a single injection : testosterone propionat effective for the first day of testosterone and fenilpropionata izokapronata begins in 24 hours after injection and continued until two weeks.

Indications

Men-postcastrationny syndrome, oligospermia, evnouhoidizm, impotence, male climacteric, etc.; Among women is breast cancer, endometriosis, mioma.

Pregnancy and lactation

Contraindicated in pregnancy.

Contraindications

Neoplasms prostate, the liver and kidneys, gipercalziemia, gipercalziuria, heart failure, fatigue, until puberty for boys, old age men pregnancy.

Patient interaction

Effect weaken induktora mikrosomaionah liver enzymes (rifampicin, barbiturates, carbamazepine, salicilata, fenilbutazon, phenytoin).

Overdosing

The drug overdose Omnadren 250 is not provided.

Storage conditions

List B. In the dark place at a temperature of 15-25 ° C

Shelf life

3 years

The registration

014397/01-2002

All products of this group

0